Purchase Order 75N95023P00307
Award Date 5/29/23
Potential Completion Date 1/31/24
Potential Value $119K
Funding Federal Agency
Contracting Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
- Not listed
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Madison, WI 53711, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a firm fixed-price Blanket Purchase Agreement (BPA) call awarded by the National Center for Advancing Translational Sciences (NCATS), a civilian agency, to Promega Corporation, a large for-profit manufacturer of scientific research and diagnostic products. The $12,103 contract is for the delivery of a HIBIT-tagged IRAK1 cell line, with a performance period ending on September 21, 2026. Promega is an experienced federal contractor, holding several indefinite delivery vehicles (IDVs)...
- This is a firm fixed-price purchase order awarded by the Department of Health and Human Services' National Institutes of Health National Center for Advancing Translational Sciences to Promega Corporation, a global life sciences company, for the supply of CELLTITER-GLO(R) ONE SOLUTION ASSAY, 500ML. The potential value of the contract is $13,292.50 and the completion date is September 15, 2023. Promega Corporation is a manufacturer of goods and a for-profit organization that has previously...
- This is a $127,908.40 firm fixed-price purchase order awarded to Promega Corporation, a global life sciences company, by the National Center for Advancing Translational Sciences (NCATS), a component of the National Institutes of Health (NIH). The award is for Promega's proprietary reagent kits and assay products, which are sole source procured due to their specialized capabilities required to support NCATS' ongoing laboratory research and high-throughput screening programs. This award was not...
- The National Center for Advancing Translational Sciences, a civilian agency within the U.S. Department of Health and Human Services, awarded a Firm Fixed Price Purchase Order contract to Promega Corporation, a for-profit manufacturer of biological research and diagnostic products. The $66,970.35 contract is for the delivery of Promega's proprietary laboratory equipment, reagents, and consumables to support the agency's biomedical research and testing programs. This award is under a $10 million...
- This is a firm fixed-price purchase order awarded by the National Center for Advancing Translational Sciences (NCATS), part of the National Institutes of Health (NIH), to Promega Corporation for $132,961.50. The order is for Promega's cytochrome P450 screening assay systems to support the Tox21 drug screening program. The assay kits measure the activity of various CYP enzymes, which are critical for evaluating drug metabolism and toxicity. This award was sole-sourced to Promega as the sole...
- This federal contract award to Promega Corporation, a global life sciences company, has a ceiling value of $83,617.40. The contract was awarded by the National Institute on Drug Abuse (NIDA), a civilian agency that is part of the National Institutes of Health (NIH). The contract is a Firm Fixed Price Purchase Order, with an ultimate completion date of September 3, 2018. It does not have a set-aside designation. Promega, as the prime contractor, will provide a range of specialized laboratory...
- This is a firm fixed-price purchase order awarded by the National Institutes of Health (NIH) on behalf of the National Center for Advancing Translational Sciences (NCATS) to Promega Corporation, a global life sciences company. The $83,800 contract is for the procurement of Promega reagents and assays to support NCATS' Antiviral Program for Pandemics. The award does not utilize a set-aside designation. The original solicitation states that NCATS' screening assays have been optimized using Promega...
- This is a $338,521.70 definitive contract awarded by the National Institute on Drug Abuse, a civilian agency under the Department of Health and Human Services, to Promega Corporation, a large business manufacturer of life science reagents and equipment. The contract, which has a fixed price, is for the provision of PROMEGA REAGENTS to support the National Center for Advancing Translational Sciences (NCATS) program. The contract does not utilize a set-aside designation. Promega has several...
- The Department of Health and Human Services National Institutes of Health National Center for Advancing Translational Sciences awarded a firm fixed price purchase order contract to Promega Corporation, a global life sciences company, for the provision of reagent kits and assays. The contract has a potential value of $22,784.00 and a completion date of July 21, 2020. Promega has previously provided DNA analysis equipment, reagents, assays, and related laboratory supplies to federal agencies...
- This federal contract award was issued by the National Institute on Drug Abuse (NIDA), a civilian agency within the Department of Health and Human Services. The $106,524 firm fixed-price purchase order was awarded to Promega Corporation, a global life sciences company, on September 1, 2015 with a completion date of September 30, 2015. The contract does not have a set-aside designation, reflecting Promega's position as a large business in the federal marketplace. Promega has supplied a range of...